Navigating Your ADTKD-UMOD Diagnosis

Receiving a diagnosis of a rare disease can feel overwhelming, especially when the name itself—Autosomal Dominant Tubulointerstitial Kidney Disease (UMOD-related), or ADTKD-UMOD—sounds like a foreign language. It is normal to feel a mix of relief at finally having an answer and anxiety about what that answer means for your future. Because this condition is rare, you may find that your primary care doctor or even a general nephrologist (kidney specialist) has limited experience with it ^[1]. This page is designed to help you navigate this new territory by explaining what the disease is, why the name has changed, and what you can expect in the years ahead.

Understanding the Name Change

If you have been searching the internet or looking through older medical records, you may have seen different names for your condition. In the past, doctors named this disease based on the symptoms they saw, which led to several different labels for the same genetic problem:

• Familial Juvenile Hyperuricemic Nephropathy (FJHN): This name focused on the fact that the disease runs in families (familial), often causes gout at a young age (juvenile hyperuricemic), and affects the kidneys (nephropathy) ^[2].
• Medullary Cystic Kidney Disease Type 2 (MCKD2): This name was used because some patients developed small fluid-filled sacs (cysts) in the middle part of the kidney (medulla) ^[3].

Modern medicine has shifted toward naming diseases after the specific gene responsible for them. Since researchers discovered that both FJHN and MCKD2 are caused by mutations in the UMOD gene, they are now grouped under the umbrella of ADTKD-UMOD ^[2][4]. The AD stands for autosomal dominant, which means only one parent needs to have the gene mutation to pass it on to their children, with a 50% chance of transmission for each pregnancy ^[3].

How Rare is ADTKD-UMOD?

ADTKD-UMOD is considered a rare disease. In one UK tertiary-center study, it had an estimated population prevalence of 9 per million ^[1]. However, it is one of the most common causes of inherited kidney failure that does not involve large cysts. Among referred families in selected ADTKD registries, about 38% are found to have the UMOD subtype ^[5].

Because it is rare, many patients spend years seeing different specialists before getting a correct diagnosis. If your doctor had to look up this condition during your appointment, it is not necessarily a sign of poor care; it is a reflection of how few cases the average physician sees in their career.

The Role of Uromodulin

The UMOD gene provides instructions for making a protein called uromodulin (also known as Tamm-Horsfall protein). This is the most abundant protein found in normal urine, and it is produced exclusively in the kidneys ^[2]. In ADTKD-UMOD, the mutation causes the uromodulin protein to fold incorrectly ^[3].

Instead of being released into the urine where it belongs, this “misfolded” protein gets stuck inside the kidney cells. Over time, the buildup of this abnormal protein causes stress and damage to the kidney’s tubules—the tiny tubes that help filter and reabsorb water and nutrients ^[2]. This leads to scarring (fibrosis) and a gradual decline in kidney function.

What to Expect: The General Course

While everyone’s experience with ADTKD-UMOD is different, the disease typically follows a pattern of progression, although the speed is highly variable.

1. Early Signs: Uric Acid and Gout

One of the earliest signs of ADTKD-UMOD is a high level of uric acid in the blood (hyperuricemia). This happens because the damaged kidney tubules cannot properly remove uric acid from the body ^[6].

• Teenage Gout: Many patients experience their first attack of gout—painful, swollen joints caused by uric acid crystals—during their teenage years or early 20s ^[7].
• Variability: While in some cohorts 87% of patients had hyperuricemia, not everyone gets gout. In some families, gout may be mild or even absent ^[5][8].

2. Progressive Kidney Decline

Unlike some other kidney diseases, ADTKD-UMOD typically does not cause blood or large amounts of protein in the urine, which means standard urine tests often look “bland” or normal ^[3]. The decline in kidney function happens over time, but is not always perfectly steady.

• Chronic Kidney Disease (CKD): Most patients will gradually move through the stages of kidney disease over several decades.
• End-Stage Renal Disease (ESRD): This is the point where the kidneys can no longer keep up with the body’s needs, requiring dialysis or a transplant. Across large groups of patients in an international cohort, the median age for reaching ESRD was 47 years ^[7]. It is essential to know that this is a cohort statistic, not a prediction for you as an individual; progression can occur substantially earlier or later.

3. Factors Influencing Progression

Several factors can influence how quickly the disease progresses:

• Biological Sex: On average in studied cohorts, men tend to reach kidney failure about four years earlier than women with the same mutation ^[7][9].
• Specific Mutation: There are many different types of mutations within the UMOD gene. However, sex and specific variant associations cannot reliably predict a particular patient’s age at kidney failure ^[9][10].

Living with a Rare Diagnosis

The journey with ADTKD-UMOD is a marathon, not a sprint. Because the progression is often measured in decades rather than months, you have time to learn about the condition, build a specialized care team, and make informed decisions about your health. While there is currently no cure for the genetic mutation itself, managing your uric acid levels and protecting your remaining kidney function are the cornerstones of modern care.